• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Energy Market
    Energy News
    Energy Stocks
    • Energy Market
    • Energy News
    • Energy Stocks

    Uranium Participation Announces Estimated Net Asset Value

    Written by Nicole Rashotte
    |
    Feb. 08, 2018 06:29AM PST

    Uranium Participation Corporation reported that its estimated net asset value at January 31, 2018 was C$459.3 million or C$3.47 per share.

     Uranium Participation Corporation (TSX:U) reported that its estimated net asset value at January 31, 2018 was C$459.3 million or C$3.47 per share.

    As quoted in the press release:

    Fair values are month-end spot prices published by Ux Consulting Company, LLC, translated at the Bank of Canada’s month-end daily exchange rate of $1.2293.On January 31, 2018, the common shares of UPC closed on the TSX at a value of CAD$3.90, which represents a 12.39% premium to the net asset value of CAD$3.47 per share.

    On December 29, 2017, the Corporation entered into an agreement with a primary UF6 conversion supplier to sell the conversion components contained in 786,241 KgU as UF6. The sale was completed on January 31, 2018 and resulted in the exchange of 786,241 KgU as UF6 for 2,054,330 pounds U3O8 plus cash consideration of US$3,538,000. In connection with this transaction, the Corporation also amended its storage arrangements with the primary supplier to provide for beneficial storage terms that are fixed for the period through December 31, 2028. This transaction has simplified UPC’s uranium holdings and, most significantly, will provide storage price certainty on a significant portion of the Corporation’s uranium holdings for a period of 11 years.

    Click here to read the full Uranium Participation Corporation (TSX:U) press release.

    uranium holdingstsx:ucanadavaleura energy inc.tsx:vle
    The Conversation (0)

    Go Deeper

    AI Powered
    Canadian flag next to uranium ore.

    5 Best-performing Canadian Uranium Stocks in 2026

    Nuclear power plant powered by uranium at dusk.

    Uranium Stocks: 5 Biggest Companies

    Latest News

    SAGA Metals Announces Closing of Over-Subscribed $10.2 Million Non-Brokered Private Placement

    SAGA Metals Closes on Title Transfer Agreement to Expand Wolverine Heavy Rare Earth Element Project in Labrador-Grab Sample Assays Included up to 21.6% TREO

    Westport to Issue Q1 2026 Financial Results on May 14, 2026

    Alvopetro Announces Q1 2026 Financial Results and Details for Our Upcoming AGM

    Angkor Resources Identifies Copper Drill Targets Adjacent To Canada Wall Copper Porphyry Project, Cambodia

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
      • Electric Vehicles
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Energy
      • Uranium
      • Oil and Gas
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES